Under the collection!

Procurement with volume can be a joy for a business enterprise and a worry for a business enterprise.

01 Centralized procurement is more and more involved

With the implementation of national centralized procurement again and again, more and more varieties and quantities are purchased in quantity, and the scope and level of involvement are becoming more and more extensive

For the pharmaceutical commercial enterprises of the distribution unit, one family is happy and the other is sad

Before the implementation of national centralized procurement, almost every pharmaceutical commercial enterprise that opened an account in a hospital, as long as the manufacturer is willing to and the variety is appropriate, the pharmaceutical commercial enterprise can distribute products to the hospital that has opened an account, and earn the part that it should receive.

Most commercial enterprises that do hospitals live in this way.

For decades, whether it is a large pharmaceutical group such as Sinopharm, China Resources Pharmaceutical, Shanghai Pharmaceutical Group, Nanjing Pharmaceutical, or small and medium-sized pharmaceutical commercial enterprises in various regions, everyone has been in peace with each other

Each does its own variety, each does its own service, fills up the vacancies, and does its best to maintain timely delivery of medicines to public hospitals.

I originally thought that this order of drug delivery would continue.

02 Widening gap between pharmaceutical and commercial enterprises

The price reduction of medicines and the implementation of volume purchases unintentionally opened the distance between pharmaceutical commercial enterprises

The increase in the variety of centralized procurement and the increase in the variety of centralized procurement will not only bring opportunities and challenges to production enterprises, but also increase the awareness of production costs; it will also bring opportunities and challenges to commercial enterprises

With large-scale, grouping, informatization and capital chains, small and weak commercial enterprises have been unable to support and bear the burden of mass procurement.

Numerous varieties of reserves, strong financial strength, advanced storage conditions, fast distribution capabilities, and a wide range of hospital account openings, which inadvertently provide convenient conditions for large-scale pharmaceutical commercial enterprises

Although the overall distribution gross profit has declined, due to the scale effect of volume procurement, part of the cost can also be digested.

However, those small and medium-sized pharmaceutical commercial enterprises that have been intensively working in hospitals for more than ten years or even decades have suffered because of their small size, shortage of funds, limited storage of their own, and the unsatisfactory staffing, even though they and the hospital are very close.

It's not that small and medium-sized businesses don't want it, but it's really a bit big to buy the cake in quantity.

Of course, it’s not a pity.

03 Quantity purchasing is accidental and inevitable

Before the national centralized procurement and local procurement, almost all pharmaceutical commercial enterprises could not predict this result.
Because the pharmaceutical distribution environment that has lasted for decades has made the decision-makers of pharmaceutical commercial enterprises accustomed to it, you earn money.
The money, I get my profit, and no one affects anyone
.

However, no one expected that the plan would never keep up with the changes.
In fact, the term mass purchasing has only suddenly become popular in the past few years
.

The emergence of volume purchases, at first glance, is accidental, but in fact it also has its inevitability
.
Because for a long time, the country and patients have long hated the phenomenon of high drug prices.
The overall price reduction of drugs is inevitable, so it is reasonable to purchase drugs in large quantities
.

As a pharmaceutical commercial enterprise, don't miss what it was like before.
Even if you can't get the distribution rights, there is no way out.
The company must not complain.
If you want to survive, you can only rely on yourself
.

The sky can't fall, there is no road on the ground, and it becomes a road if there are more people walking
.

Procurement with a large amount was originally the result of a few happy and many sorrows.
Once you figure it out, don’t worry anymore, because sorrow will never solve the survival problem of small and medium-sized pharmaceutical companies
.

People often say that when you are forced to close one window, you will inevitably open another window.
It's just that many people don't see it, and they still complain about the injustice of the world to them
.

If small and medium-sized pharmaceutical commercial enterprises still remain in this mindset, the outcome of waiting for them must be forgotten by the market.
Can such pharmaceutical commercial enterprises still exist over time? You must know this truth.
It is not others, but yourself that weeds out yourself.
This is the law of the market and the objective law, and it does not depend on people's will
.

04 Conclusion: There is still a way out

To sum up, mass purchase will definitely shake the current pharmaceutical commercial enterprises.
Some commercial enterprises that originally distributed to hospitals withdrew because they could not obtain distribution rights
.

However, it should also be noted that the quantity procurement is only the national collection of varieties, not the entire variety of hospitals.
Other hospital varieties other than the collection can still be delivered, but the overall delivery volume will be affected to a certain extent
.

Of course, there are still channels to go.
With the transformation of business forms, the operating model of commercial companies can also be transformed
.

The market is still very large.
It just depends on how to explore.
As a hospital company, it can still do the business of controlling sales.
Nowadays, some pharmaceutical commercial companies have made this expansion
.

The same is the same, as long as you use your heart, there will be no obstacles that you can't get past.
Procurement with a large amount will have an impact, but it will not be too big, because the pharmaceutical commercial enterprises that cannot get the distribution rights have already had their own future plans
.

Only those pharmaceutical commercial enterprises that are prepared can take the initiative to control the destiny of their own enterprises
.